why choose us

First received: November 27, 2024

Clinical Trial: A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Staphylococcus (S.) Aureus Infection

Study Type: INTERVENTIONAL


Official Title: A Phase I, Randomized, Double-Blinded and Controlled Trial to Evaluate Safety and Immunogenicity of an Investigational Multicomponent Staphylococcus Aureus Toxoid Vaccine (LTB-SA7) in Healthy Adults.

Brief Summary: In this study, the candidate vaccine LTB-SA7 will be tested for safety and immunogenicity in healthy adults.

Read more